rdf:type |
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0030705,
umls-concept:C0079419,
umls-concept:C0080103,
umls-concept:C0205179,
umls-concept:C0205210,
umls-concept:C0440743,
umls-concept:C0443252,
umls-concept:C0449438,
umls-concept:C0677886,
umls-concept:C0871261,
umls-concept:C1274040,
umls-concept:C1514162,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
1B
|
pubmed:dateCreated |
2006-6-2
|
pubmed:abstractText |
The aim of this retrospective study was to assess whether p53 gene status has any predictive or prognostic relevance in patients with advanced, poorly-differentiated serous epithelial ovarian cancer treated with paclitaxel- plus platinum-based chemotherapy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
687-93
|
pubmed:meshHeading |
pubmed-meshheading:16739339-Adult,
pubmed-meshheading:16739339-Aged,
pubmed-meshheading:16739339-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16739339-Cystadenocarcinoma, Serous,
pubmed-meshheading:16739339-Disease-Free Survival,
pubmed-meshheading:16739339-Exons,
pubmed-meshheading:16739339-Female,
pubmed-meshheading:16739339-Genes, p53,
pubmed-meshheading:16739339-Humans,
pubmed-meshheading:16739339-Immunohistochemistry,
pubmed-meshheading:16739339-Middle Aged,
pubmed-meshheading:16739339-Neoplasm Staging,
pubmed-meshheading:16739339-Organoplatinum Compounds,
pubmed-meshheading:16739339-Ovarian Neoplasms,
pubmed-meshheading:16739339-Paclitaxel,
pubmed-meshheading:16739339-Polymorphism, Genetic,
pubmed-meshheading:16739339-Treatment Outcome
|
pubmed:articleTitle |
P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome.
|
pubmed:affiliation |
Department of Procreative Medicine, Division of Gynecology and Obstetrics, University of Pisa, Italy. a.gadducci@obgyn.med.unipi.it
|
pubmed:publicationType |
Journal Article
|